We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+15.85%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$285M
AUM Growth
+$81.2M
Cap. Flow
+$62.5M
Cap. Flow %
21.89%
Top 10 Hldgs %
40.02%
Holding
95
New
33
Increased
14
Reduced
26
Closed
19

Top Sells

Rank Stock Value
1
NVRO
NEVRO CORP.
NVRO
+$6.3M
2
INCY icon
Incyte
INCY
+$4.81M
3
AGN
Allergan plc
AGN
+$4.66M
4
GKOS icon
Glaukos
GKOS
+$3.02M
5
UAL icon
United Airlines
UAL
+$2.92M

Sector Composition

Rank Sector Weight
1 Healthcare 28.33%
2 Technology 16.3%
3 Communication Services 13.78%
4 Consumer Discretionary 5.9%
5 Materials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$2.95T
$3.45M 1.21%
50,000
-20,000
-29% -$1.37M
AERI
27
DELISTED
Aerie Pharmaceuticals
AERI
$3.42M 1.2%
65,000
-30,000
-32% -$1.4M
LOXO
28
DELISTED
Loxo Oncology, Inc
LOXO
$3.37M 1.18%
+42,000
New +$2.33M
SUM
29
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$3.32M 1.16%
118,592
EXAS
30
DELISTED
Exact Sciences
EXAS
$3.22M 1.13%
+90,946
New +$2.81M
MCD icon
31
McDonald's
MCD
$194B
$3.13M 1.09%
+20,400
New +$2.95M
HDB icon
32
HDFC Bank
HDB
$122B
$3.04M 1.07%
140,000
-56,000
-29% -$1.17M
META icon
33
PUT
Meta Platforms (Facebook)
META
$1.51T
$3.02M 1.06%
+20,000
New +$2.97M
AVXS
34
DELISTED
AveXis, Inc. Common Stock
AVXS
$3M 1.05%
+36,500
New +$2.74M
SHOP icon
35
Shopify
SHOP
$170B
$2.96M 1.04%
340,000
-60,000
-15% -$508K
CTLT
36
DELISTED
CATALENT, INC.
CTLT
$2.91M 1.02%
+83,000
New +$2.73M
MTN icon
37
Vail Resorts
MTN
$5.53B
$2.9M 1.02%
14,300
-200
-1% -$40.3K
JAZZ icon
38
Jazz Pharmaceuticals
JAZZ
$16.1B
$2.88M 1.01%
18,500
+3,500
+23% +$535K
ADSK icon
39
PUT
Autodesk
ADSK
$50.7B
$2.77M 0.97%
+27,500
New +$2.72M
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
$2.71M 0.95%
29,000
-21,000
-42% -$1.28M
BLUE
41
DELISTED
bluebird bio
BLUE
$2.63M 0.92%
1,930
+463
+32% +$559K
MDSO
42
DELISTED
Medidata Solutions, Inc.
MDSO
$2.54M 0.89%
+32,500
New +$2.27M
SHW icon
43
Sherwin-Williams
SHW
$87.5B
$2.46M 0.86%
+21,000
New +$2.35M
ICUI icon
44
ICU Medical
ICUI
$4.14B
$2.42M 0.85%
+14,000
New +$2.25M
CNC icon
45
Centene
CNC
$31.2B
$2.4M 0.84%
60,000
-48,000
-44% -$1.81M
SLCA
46
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$2.38M 0.83%
+67,000
New +$2.64M
SGI
47
Somnigroup International
SGI
$15.2B
$2.24M 0.79%
+168,000
New +$1.98M
GWPH
48
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.21M 0.77%
22,000
-8,000
-27% -$861K
APPN icon
49
Appian
APPN
$2.02B
$2.18M 0.76%
+120,000
New +$2.17M
ANET icon
50
Arista Networks
ANET
$211B
$2.17M 0.76%
232,000
-184,000
-44% -$1.67M

Similar funds

Atika Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Atika Capital Management held 95 positions worth $285M, up 40% from $204M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Atika Capital Management deployed $62.5M of net new capital in Q2 2017, opening 33 new positions and adding to 14 existing holdings. Its largest new stake was American Airlines Group: 121,000 shares worth $6.09M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Glaukos, an estimated $3.02M trimmed.

  • Atika Capital Management's largest Q2 2017 buy was American Airlines Group: 121,000 shares worth $6.09M.
  • Atika Capital Management added most to Align Technology in Q2 2017, an estimated $5.29M increase.
  • Atika Capital Management's biggest Q2 2017 reduction was Glaukos, cutting an estimated $3.02M.
  • Atika Capital Management fully exited NEVRO CORP. in Q2 2017, selling an estimated $6.3M.
  • Atika Capital Management's ten largest holdings make up 40% of its $285M portfolio in Q2 2017.
  • Atika Capital Management opened 33 new positions and closed 19 in Q2 2017.
  • Atika Capital Management's portfolio value rose 40% quarter-over-quarter to $285M.

Based on Atika Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.